JP2019537026A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019537026A5 JP2019537026A5 JP2019530087A JP2019530087A JP2019537026A5 JP 2019537026 A5 JP2019537026 A5 JP 2019537026A5 JP 2019530087 A JP2019530087 A JP 2019530087A JP 2019530087 A JP2019530087 A JP 2019530087A JP 2019537026 A5 JP2019537026 A5 JP 2019537026A5
- Authority
- JP
- Japan
- Prior art keywords
- sample
- excitation
- risk factor
- output signal
- input signal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 18
- 230000005284 excitation Effects 0.000 claims 11
- 238000005259 measurement Methods 0.000 claims 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 4
- 239000003153 chemical reaction reagent Substances 0.000 claims 4
- 239000008103 glucose Substances 0.000 claims 4
- 239000008280 blood Substances 0.000 claims 3
- 210000004369 blood Anatomy 0.000 claims 3
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 claims 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 claims 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 claims 2
- 230000003647 oxidation Effects 0.000 claims 2
- 238000007254 oxidation reaction Methods 0.000 claims 2
- 102000001554 Hemoglobins Human genes 0.000 claims 1
- 108010054147 Hemoglobins Proteins 0.000 claims 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 claims 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 claims 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims 1
- 229960005070 ascorbic acid Drugs 0.000 claims 1
- 235000010323 ascorbic acid Nutrition 0.000 claims 1
- 239000011668 ascorbic acid Substances 0.000 claims 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims 1
- 235000012000 cholesterol Nutrition 0.000 claims 1
- 229960003638 dopamine Drugs 0.000 claims 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims 1
- 229960005489 paracetamol Drugs 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims 1
- 229940116269 uric acid Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662430232P | 2016-12-05 | 2016-12-05 | |
| US62/430,232 | 2016-12-05 | ||
| PCT/IB2017/057584 WO2018104835A1 (en) | 2016-12-05 | 2017-12-01 | Risk factor monitoring |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019537026A JP2019537026A (ja) | 2019-12-19 |
| JP2019537026A5 true JP2019537026A5 (enExample) | 2021-01-21 |
| JP7074753B2 JP7074753B2 (ja) | 2022-05-24 |
Family
ID=60788637
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019530087A Active JP7074753B2 (ja) | 2016-12-05 | 2017-12-01 | リスク因子モニタリング |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11353417B2 (enExample) |
| EP (1) | EP3548881A1 (enExample) |
| JP (1) | JP7074753B2 (enExample) |
| CN (1) | CN110249219B (enExample) |
| CA (1) | CA3045090A1 (enExample) |
| WO (1) | WO2018104835A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3157134A1 (en) * | 2019-11-07 | 2021-05-14 | Renjith MENON | Saliva collection and testing system |
| US11872035B2 (en) | 2020-08-04 | 2024-01-16 | Ascensia Diabetes Care Holdings Ag | Continuous analyte monitoring sensor calibration and measurements by a connection function |
| CN114242253B (zh) * | 2022-02-21 | 2022-05-17 | 深圳大学 | 一种用于糖尿病酮症酸中毒预警的健康管理方法及系统 |
| CN118111933B (zh) * | 2023-10-31 | 2025-04-04 | 南方医科大学南方医院 | 基于尿酸单钠晶体生长速率评估痛风发作风险的设备 |
| CN120232970A (zh) * | 2023-12-28 | 2025-07-01 | 江苏鱼跃凯立特生物科技有限公司 | 一种血糖浓度计算方法及传感器 |
| CN120232968A (zh) * | 2023-12-28 | 2025-07-01 | 江苏鱼跃凯立特生物科技有限公司 | 一种测试生物样品中分析物的方法、传感器及系统 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004028887A (ja) | 2002-06-27 | 2004-01-29 | Yamaguchi Technology Licensing Organization Ltd | 分子鋳型膜を利用したコレステロールセンサの開発およびそれを用いる非侵襲的なコレステロール計測法および機器 |
| CN100432660C (zh) * | 2003-05-07 | 2008-11-12 | 黄椿木 | 抛弃式电化学式感测试片的结构及其制作方法 |
| ES2571929T3 (es) * | 2004-05-26 | 2016-05-27 | Region Nordjylland | Procedimiento para determinar la cantidad de CD36 circulante |
| CA2603542C (en) | 2005-04-08 | 2014-01-14 | Bayer Healthcare Llc | Oxidizable species as an internal reference in control solutions for biosensors |
| WO2007013915A1 (en) | 2005-07-20 | 2007-02-01 | Bayer Healthcare Llc | Gated amperometry |
| WO2007040913A1 (en) | 2005-09-30 | 2007-04-12 | Bayer Healthcare Llc | Gated voltammetry |
| CN101437443B (zh) * | 2006-05-08 | 2011-11-30 | 拜尔健康护理有限责任公司 | 生物传感器用的异常输出检测系统 |
| EP3753481B1 (en) | 2006-10-24 | 2024-07-17 | Ascensia Diabetes Care Holdings AG | Transient decay amperometry device |
| CA2700507C (en) | 2007-09-24 | 2018-05-29 | Bayer Healthcare Llc | Multi-region and potential test sensors, methods, and systems |
| CN101999073B (zh) | 2007-12-10 | 2013-12-18 | 拜尔健康护理有限责任公司 | 斜率式补偿 |
| EP3395954B1 (en) | 2007-12-10 | 2020-07-01 | Ascensia Diabetes Care Holdings AG | Rapid-read gated amperometry |
| US20090305317A1 (en) | 2008-06-05 | 2009-12-10 | Brauer Jacob S | User interface for testing device |
| CN105353013B (zh) * | 2008-07-10 | 2020-01-14 | 安晟信医疗科技控股公司 | 识别样本中的电离物质的方法 |
| EP2373984B1 (en) * | 2008-12-08 | 2022-11-30 | Ascensia Diabetes Care Holdings AG | Biosensor signal adjustment |
| CN103003692B (zh) | 2010-03-22 | 2015-01-14 | 拜尔健康护理有限责任公司 | 用于生物传感器的剩余补偿 |
| MX367439B (es) | 2010-06-07 | 2019-08-22 | Ascensia Diabetes Care Holdings Ag | Sistema de gestion de llenado insuficiente para un biosensor. |
| BR112012031166A2 (pt) | 2010-06-07 | 2018-02-27 | Bayer Healthcare Llc | compensação baseada eminclinação incluindo sinais de saída secundários |
| US8615366B2 (en) * | 2010-10-15 | 2013-12-24 | Roche Diagnostics Operations, Inc. | Handheld diabetes management device with bolus calculator |
| JP2012247338A (ja) | 2011-05-30 | 2012-12-13 | Gunze Ltd | 計測表示装置 |
| EP3315123B1 (en) * | 2011-09-21 | 2019-08-21 | Ascensia Diabetes Care Holdings AG | Analysis compensation including segmented signals |
| US20130116526A1 (en) * | 2011-11-09 | 2013-05-09 | Telcare, Inc. | Handheld Blood Glucose Monitoring Device with Messaging Capability |
| JP2013242171A (ja) | 2012-05-18 | 2013-12-05 | Tanita Corp | 濃度測定装置 |
| CA2879841C (en) * | 2012-07-27 | 2018-06-12 | Bern Harrison | System and method for detecting used and dried sensors |
| US9244036B2 (en) * | 2012-11-16 | 2016-01-26 | Cilag Gmbh International | System and method for determination of a concentration of at least one interfering substance and correction of glucose concentration based on the concentration of the interfering substance |
| CA2902512A1 (en) | 2013-03-14 | 2014-10-02 | Bayer Healthcare Llc | Normalized calibration of analyte concentration determinations |
| EP2990784B1 (en) * | 2013-04-26 | 2017-12-20 | Panasonic Healthcare Holdings Co., Ltd. | Liquid sample measurement method |
| US9738916B2 (en) | 2013-07-08 | 2017-08-22 | Panasonic Healthcare Holdings Co., Ltd. | Blood component measurement device and blood component measurement method |
| AU2015253309B2 (en) * | 2014-04-28 | 2021-02-25 | The Regents Of The University Of California | Unobtrusive wireless electronic systems for monitoring and facilitating patient compliance |
| EP3485265B1 (en) * | 2016-07-12 | 2025-03-12 | Ascensia Diabetes Care Holdings AG | Method for electrochemical analysis by use of alternating output signals from two electrodes |
-
2017
- 2017-12-01 JP JP2019530087A patent/JP7074753B2/ja active Active
- 2017-12-01 WO PCT/IB2017/057584 patent/WO2018104835A1/en not_active Ceased
- 2017-12-01 CN CN201780085383.9A patent/CN110249219B/zh active Active
- 2017-12-01 CA CA3045090A patent/CA3045090A1/en not_active Abandoned
- 2017-12-01 US US16/466,938 patent/US11353417B2/en active Active
- 2017-12-01 EP EP17818627.6A patent/EP3548881A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019537026A5 (enExample) | ||
| JP7066673B2 (ja) | ２つの電極からの交替する出力信号の使用による電気化学分析のための方法 | |
| EP2519817B1 (en) | Method for measuring analyte concentration in a liquid sample | |
| TW200745543A (en) | System and methods for providing corrected analyte concentration measurements | |
| EP2341342A3 (en) | Systems, devices, and methods for measuring whole blood hematocrit based on initial fill velocity | |
| US11353417B2 (en) | Risk factor monitoring | |
| RU2015105949A (ru) | Система и способы учета интерферентных веществ в глюкозном биодатчике | |
| CN107209174A (zh) | 通过交流电阻抗相角检测以确定电化学红细胞比容的系统和方法 | |
| Biedermann et al. | Agreement between Coaguchek XS and STA-R Evolution (Hepato Quick) INR results depends on the level of INR | |
| JP2016510120A5 (enExample) | ||
| US20130204108A1 (en) | Vital information measurement device and vital information measurement method employing same | |
| TN2022000166A1 (en) | Adjustment method for adjusting a setup for an analytical method | |
| RU2663084C2 (ru) | Портативное контрольно-измерительное устройство со схемным блоком моделирования тест-полоски рабочего диапазона | |
| CN105026921A (zh) | 分析物检测仪表和相关使用方法 | |
| ElSaboni et al. | Empirical model for identifying protein concentrations in wound using cyclic voltammetry | |
| Anoop et al. | Simulation of a multi-strip blood glucometer | |
| US9151730B2 (en) | Method for determining the electrochemical characteristic of a test strip | |
| JP5783891B2 (ja) | 計測表示装置 | |
| RU2654399C2 (ru) | Устройство для электродиагностики твердых тканей зуба | |
| US20170363566A1 (en) | Method of Determining Parameters of a Test Fluid | |
| CA2968920A1 (en) | Verifying operation of a meter | |
| DE102013227125A1 (de) | Verfahren zur Bestimmung eines hämatokritabhängigen Messsignals bei der Bestimmung eines Analyten aus Vollblut unter Verwendung von enzymatisch-voltammetrischen Einmalgebrauchs-Sensoren | |
| CN104523261A (zh) | 生物电检测中前端配置方案的一种测评方法 |